# K251422: BD Saf-T-Intima™ Subcutaneous Catheter System

- Pathway: 510(k) (Traditional)
- Applicant: Becton Dickinson Infusion Therapy Systems, Inc.
- Decided: Oct 8, 2025 after 154 days
- Product code: FOZ (Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days)
- Device class: 2
- Regulation: 21 CFR 880.5200
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K013800 (2001). 1 ancestor in all.
No later device cites it as a predicate yet.
0 of 2 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K013800: Insyte, Angiocath, Insyte Autoguard, Angiocath Autoguard, Autoguard Pro, Intima, and Saf-T-Intima Intravascular Cathete, Becton Dickinson Infusion Therapy Systems, Inc. (2001) Summary page 5.

## Indications for use
BD Saf-T-Intima™ Subcutaneous Catheter System is intended to be inserted into a patient’s subcutaneous tissue for short term use for the administration of fluids and medications. This device is also intended to be inserted into a patient’s peripheral venous system for short term use to administer fluids or sample blood. This device may be used for any patient population with consideration given to adequacy of subcutaneous tissue or vascular anatomy, procedure being performed, fluids being infused, and duration of therapy.

Source page: https://510kreport.com/device/K251422
Methodology: https://510kreport.com/methodology